Synthesis and antimicrobial evaluation of novel di-triazoles and 4-arylidene amino 4,5 dihydro-1H-[1,2,4] triazole-5-one derivatives

Turkish Journal of Chemistry

Volumn 32, Issue 4, 2008, Pages 441-455

  Ünver, Yasemin ^a   Düǧdü, Esra ^a   Sancak, Kemal ^a   Er, Mustafa ^a   Karaoǧlu, Şengül Alpay ^b  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

Author keywords

Antimicrobial activity; Schiff base; Triazole 5 one; X ray

Indexed keywords

EID: 48249136967     PISSN: 13000527     EISSN: 13036130     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Tsukuda, T.; Shiratori, Y.; Watanabe, M.; Ontsuka, H.; Hattori. K.; Shirai, M.; Shimma, N. Bioorg. Med. Chem. Lett. 1998, 8, 1819-1824.
2. Witkoaski, J. T.; Robins, R. K.; Sidwell, R.. W.; Simon, L. N. J. Med. Chem. 1972, 15, 1150-1154.
3. Heubach, G.; Sachse, B.; Buerstell, H. Ger. Offen. 2, 826-760 (1979), Chem. Abstr. 92, 181200h (1975).
4. Tanaka, G. Japan Kokai 973, 7495 (1974), Chem. Abstr. 82, 156320h (1975).
5. Griffin, D. A.; Mannion, S. K. Eur. Pat. Appl. EP (1986) 199,474, Chem. Abstr. 106, 98120u (1987).
6. a) Hanna, N. B.; Dimitrijevich, S. D.; Larson, S. B.; Robsin R. K.; Revankar, G. R,. J. Heterocycl. Chem. 1988, 25, 1857-1868.
7. b) Jenkins, B T. C; Stratfort, I. J. Anticancer Drug. Des. 1987, 4, 145-160.
8. Husain, M. I.; Amir, M. J. Indian Chem. Soc. 1986 63, 317-319, Chem. Abstr. 106, 176272h (1987).
9. Chiu, S.-H.L.; Huskey, S. -E.W. Drug Metabol. Dispos. 1998, 26, 838-847.
10. Eliott, R.; Sunley R. L.; Griffin, D. A. UK Pat Appl GB 2, 175-301 (1986), Chem. Abstr. 107, 134310n (1987).
11. Chaaban, I.; Oji, O. O. J. Indian Chem. Soc. 1984, 61, 523-525, Chem. Abstr. 102, 62157q (1985).
12. Omar, A. M. E.; Aboul Wafa, O. M. J. Heterocycl. Chem. 1984, 21, 1415-1417.
13. Francois, C.; Claudine, J. Fr Patent (1984) 2 539,127, Chem. Abstr. 102, 95677n (1985).
14. Foroumadi, A.; Soltani F.; Moshafi M. F.; Ashraf-Askari, R, IL Farmaco 2003, 58, 1023-1028.
15. Foroumadi, A.; Mansouri, S.; Kaini Z.; R,ahmani, A, Eur. J. Med. Chem. 2003, 38, 851-854.
16. Foroumadi, A.; Mirzai, M.; Shafiee, A. IL Farmaco 2001, 56, 621-623.
17. Ulusoy, N.; Gürsoy, A.; Ötük, G. IL Farmaco 2001, 56, 947-952.
18. İskeleli, N.; Işik, Ş.; Sancak, K.; Şaşmaz, S.; Ünver, Y.; Er, M. Acta Crytallographica Section C 2005, 61, 363-365.
19. Collin, X.; Sauleau A.; Coulon, J. Bioorg. Med. Chem. 2003, 13, 2601-2605.
20. Ram, V. J.; Mishra, L. N.; Pandey, H.; Kushwaha, D. S.; Pieters, Luc A. C.; Vlietinck, A. J. J. Heterocycl. Chem. 1990, 27, 351-355.
21. Goss, P. E.; Strasser-Weippl, K. Best Pract. Res. Clin. End. Met. 2004, 18, 113-130.
22. Santen, J. R. Steroids, 2003, 68, 559-567.
23. Clemons, M.; Colemon, R.E.; Verma, S. Cancer Treat. Rew. 2004, 30, 325-332.
24. Ikizler A.; Sancak, K. Rov. Roumaine Chim. 1998, 43, 133-138.
25. Demirbaş, N.; Ugurluoglu R.; Demirbaş, A. Bioorg. Med. Chem. 2002, 10, 3717-3123.
26. Bradshaw, J. S.; Izatt, R. M. Acc. Chem. Res., 1997, 30, 338-342.
27. İkizler A. A.; Sancak, K. Collect. Czech. Commun. 1995, 60, 903-909.
28. Demirbaş N.; Ugurluoglu R., Turk. J. Chem. 2004, 28, 679-690.
29. Yilmaz, I.; Arslan, N. B.; Kazak, C.; Sancak, K.; Er, M. Acta Crytallographica Section E 2006, 62, 2493-2494.
30. Perez, C.; Bazerque, M. Acta Biol. Med. Exp. 1990, 15, 113-115.
31. Ahmad, I.; Mehmood, Z.; Mohammed, F. J. Ethnopharmacol. 1998, 62, 183-193.
32. Stoe & Cie (2002). X-AREA (Version 1.18) and X-RED32 (Version 1.04). Stoe & Cie, Darmstadt, Germany.
33. Sheldrick G.M. (1997), SHELXS97 and SHELXL97, University of Göttingen, Germany.
34. Burnett, M. N.; Johnson, C. K. (1996). ORTEPIII. Report ORNL-6895. Oak Ridge National Laboratory, Tennessee, USA.
35. Farrugia, L. J. J. Appl. Crystallogr. 1999, 32, 837.
36. Nardelli, M. J. Appl. Cryst., 1995, 28, 659.
37. Köysal, Y.; Işik, Ş.; Özdemir, Z.; Bilgin, A. A. Analytical Science 2007, 23, 177.
38. Bernstein, J.; Davies, R. E.; Shimoni, L.; Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555.